E-cigarettes offered to cancer patients who refuse to quit smoking
NCT ID NCT07039292
First seen Sep 30, 2025 · Last updated Jun 23, 2026 · Updated 28 times
Summary
This study looks at whether giving e-cigarettes to cancer patients who smoke—and who have turned down standard quitting help—can help them switch away from regular cigarettes. About 208 adults with cancer will either receive an e-cigarette and support to switch, or standard care with referrals to quit programs. The main goal is to see how many completely stop smoking cigarettes after 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ONCOLOGY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
e-cigarette
What this could lead to
If it works, this could offer a practical way to reduce smoking-related harm for cancer patients who cannot or will not quit using standard methods.
What could go wrong
This is a small, early-stage study (208 people) and e-cigarettes are not risk-free. Long-term safety and effectiveness are unknown, and results may not apply to all smokers.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.